February 3, 2014 -- The U.S. Food and Drug Administration today approved the expanded use of the Dexcom G4 Platinum Continuous Monitoring System for patients with diabetes ages 2 to 17 years. The G4 Platinum System, which monitors blood ...
Tags: FDA
ResearchDx,LLC of Irvine,California,USA today announced an expansion of its operations to focus on the important Middle East clinical laboratory and diagnostics markets. As part of this initiative,ResearchDx will be exhibiting at the 2014 ...
Tags: ResearchDx, Diagnostics Organization, health
US-based ResearchDx has announced an expansion of its operations to focus on the important Middle East clinical laboratory and diagnostics markets. As part of this initiative,ResearchDx will be exhibiting at the 2014 Arab Health Congress ...
Aligned with its commitment to help move reproductive health management forward, Beckman Coulter Diagnostics has received clearance for its new Access Total βhCG (5th IS) assay from the U.S. Food and Drug Administration (FDA) 510(k), ...
Illumina, Inc. (NASDAQ:ILMN) today announced it has entered into a multi-year licensing agreement with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, related to the use of Illumina's ...
Tags: Illumina, multi-year licensing agreement, Quest Diagnostics
Siemens Healthcare Diagnostics and Pfizer have entered into a master collaboration agreement to design, develop and commercialize diagnostic tests for therapeutic products across Pfizer’s pipeline. Pursuant to the terms of the ...
Tags: Siemens, Pfizer, Companion Diagnostics
MagneMotion, a provider of products and transport systems based on Linear Synchronous Motor (LSM) technology, has announced a strategic partnership with Siemens Healthcare Diagnostics, whereby Siemens has acquired an exclusive license for ...
NanoString Technologies, a provider of life science tools for translational research and molecular diagnostic products, has announced the availability of the nCounter Dx analysis system for high-complexity, CLIA-certified laboratories. ...
Tags: NanoString, DX Analysis System
Laboratory Corporation of America Holdings (LabCorp) has announced that its fourth generation human immunodeficiency virus (HIV) antigen/antibody combination assay for screening of HIV infection is now available. In addition to the HIV ...
Tags: hiv, hiv antigen, hiv cure, hiv assays
Medical device company Aethlon Medical has launched a new subsidiary Exosome Sciences to pursue exosome-based strategies for diagnosing and monitoring the progression of cancer, infectious disease and other life-threatening conditions. ...
Tags: Medical device, Aethlon Medical
Glucose is produced by the conversion of carbohydrates into sugar in the body. This is a normal process in a normal person but can the process can be entirely different for a person suffering from diabetes. Patients that suffer from ...
NanoString Technologies, a provider of life science tools for translational research and molecular diagnostic products, has obtained the US Food and Drug Administration (FDA) 510(k) clearance for its Prosigna breast cancer prognostic gene ...
Genetic Technologies has received its clinical laboratory permit from the New York State Department of Health (DoH). Genetic Technologies received a positive Laboratory Evaluation Report with "No significant deficiencies" following an ...
Tags: Health, Medicine, Genetic Technologies
The U.S. Food & Drug Administration (FDA) has categorized Cepheid's Xpert MTB/RIF test as 'moderate complexity' under the Clinical Laboratory Improvement Amendments (CLIA). Xpert MTB/RIF test is designed for the rapid molecular detection ...
Tags: moderate Complexity, Medicine
The US Food and Drug Administration (FDA) has approved Alere's pre-market application (PMA) for the commercialization of Alere Determine HIV 1/2 Ag/Ab Combo in the country. The FDA approval allows the marketing of Alere Determine HIV 1/2 ...
Tags: Alere Determine, Medicine